Development and validation of a nomogram for predicting the overall survival of patients with testicular cancer.
Haohui YuBin FengYunrui ZhangJun LyuPublished in: Cancer medicine (2023)
We developed and validated a nomogram for predicting the survival rate of testicular cancer patients at 3, 5, and 10 years after diagnosis. This nomogram has better discrimination, calibration, and clinical validity than the AJCC staging system. This indicates that the nomogram can be used to predict the survival of testicular cancer patients effectively, and provide a reference for patient treatment strategies.